Medication info
Sitarren Tablet 25 mg (Sitagliptin Hydrochloride Monohydrate)

Sitarren Tablet 25 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.35mg / 1 tablet
Manufacturer / importer
Nexfarm Korea Co., Ltd.
Appearance
Pink, round, biconvex film-coated tablet
Packaging
30 tablets/box [(10 tablets/PTP x 3)]
Approval status
Active

MFDS item code 202005701 · Approved 2020.08.07 · Insurance code 662504580

Summary

Main use
Improvement of blood glucose control in type 2 diabetes
Who takes it
Adults
Adult dose
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy, with a maximum daily dose of 100 mg. This medicine may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for use, 5. General precautions). Patients with renal impairment Since dose adjustment according to renal function is required, evaluation of renal function is recommended before administration of this medicine and periodically thereafter. 1. No dose adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Nexfarm Korea Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes

  • Type 2 diabetes
  • difficulty in blood sugar control
View approved original text

This medication helps patients with type 2 diabetes to effectively control their blood sugar levels. It can be administered alone while combining with diet and exercise, and is initiated as monotherapy during early treatment. If a patient has never used diabetes medications and finds it difficult to control blood sugar with monotherapy, it can be used in combination with metformin. Furthermore, if there is insufficient effect with monotherapy of sulfonylureas, metformin, thiazolidinediones, or insulin, this medication can be added for combination therapy. Additionally, it can be used in combination when treatment with two or more medications is not sufficient for blood sugar control, allowing for personalized treatment for patients. It is used to improve blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

This medicine is administered at 100 mg once daily as monotherapy or in combination therapy, with a maximum daily dose of 100 mg. This medicine may be taken with or without food. When administered concomitantly with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for use, 5. General precautions). Patients with renal impairment Since dose adjustment according to renal function is required, evaluation of renal function is recommended before administration of this medicine and periodically thereafter. 1. No dose adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.

Precautions

This medication may cause serious allergic reactions rarely, so if symptoms such as skin rash or difficulty breathing occur within 3 months after administration, discontinue use immediately and consult a doctor. This medication poses a risk of pancreatitis, which is inflammation of the pancreas, so if symptoms such as abdominal pain, nausea, or vomiting occur, prompt medical evaluation is necessary. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, nor in cases of allergy to this medication or its ingredients. Patients with impaired renal function need dose adjustment, so regular renal function tests should be performed, and it should be taken according to a doctor’s instructions. This medication may cause side effects including headache, upper respiratory infection, nasopharyngitis, diarrhea, nausea, constipation, muscle pain, limb pain, back pain, pruritus, thrombocytopenia, dyspepsia, dizziness, increased triglycerides, increased low-density lipoproteins, hyperglycemia, hypertension, weight loss, and erectile dysfunction whether used alone or in combination with other diabetes medications; persistent symptoms should be reported to medical professionals. If taken with insulin or sulfonylureas, the risk of hypoglycemia may increase, necessitating periodic blood sugar checks and immediate action if hypoglycemic symptoms arise. If severe joint pain or symptoms such as blisters occur during medication use, notify a doctor promptly and discontinue use. This medication is not recommended for women during pregnancy or breastfeeding, so it is essential to consult with healthcare professionals if applicable. Elderly patients may experience reduced renal function, thus requiring dose adjustments and regular renal function tests. In case of overdose, immediate medical attention is needed for appropriate treatment, and this medication can be partially removed through hemodialysis. This medication has low potential for drug interactions, but it should be disclosed to healthcare professionals when taking specific medications.

Side effects

  • Anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infection
  • nasopharyngitis
  • headache
  • diarrhea
  • abdominal pain
Show 32 more
  • nausea
  • constipation
  • vomiting
  • rash
  • urticaria
  • cutaneous vasculitis
  • elevated liver enzymes
  • acute renal failure
  • severe joint pain with disability
  • vesicular pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • dyspepsia
  • dizziness
  • increased ALT
  • increased AST
  • elevated serum triglycerides
  • gastritis
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container protected from air exposure, ideally at room temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication.

Appearance and packaging

Appearance

Pink, round, biconvex film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.